ASGCT News

Filter By

Recent Articles

Gene, Cell, & RNA Therapy Landscape: Q2 2021

David M. Barrett, J.D., M.S. | July 23, 2021

Highlights in the second quarter of 2021 include the approval of a new gene therapy in Japan, the expansion of gene therapy approvals to three new countries, and more!

Read Full Story

ASGCT Addresses Challenges and Potential Solutions to Development in LMICs

Johnny Mahlangu, BSc, MBBCh, MMed, FCPath  | July 14, 2021

While there has been significant clinical advancement of gene therapy in the US, EU, and Japan, low- and middle-income countries (LMICs) do not have the same access to resources needed for development.

Read Full Story

ASGCT Grapples With Development for Ultra-Rare Diseases

ASGCT Staff | July 01, 2021

Read some highlights from last week's Forum on Gene Therapy for Underserved Populations.

Read Full Story

Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020

ASGCT Staff | July 01, 2021

Molecular Therapy-Oncolytics' 75% increase, to 7.200, was the highest impact factor jump across more than 50 Cell Press journals.

Molecular Therapy
Read Full Story

Twitter for Scientists: Tips from Nicole Paulk, Ph.D.

Catherine Gillespie | June 18, 2021

If you're interested in getting started or becoming more established on Twitter, Nicole Paulk, Ph.D., shared some tips during ASGCT's Academic Writing Dos and Don'ts seminar.

Read Full Story

Getting to Know Ralph Yaniz, LGMD2L Patient and Advocate

Kenji Rowel Lim | June 11, 2021

We talked to Ralph Yaniz about his experience with limb girdle muscular dystrophy type 2L (LGMD2L), his advocacy activities, and more.

Read Full Story

Global Speakers Address Developing Gene Therapies in Low- and Middle-Income Countries

Martín Bonamino, Ph.D. | June 03, 2021

Martín Bonamino, Ph.D., provides a recap of the first Annual Meeting session organized by ASGCT's Global Outreach Committee.

Annual Meeting
Read Full Story

Q&A with Bruce Pyenson

Francesca Cook, MPH | June 03, 2021

ASGCT Government Relations Committee Chair Francesca Cook talked to Bruce Pyenson about reinsurance and risk, U.S. healthcare, and how the system will need to adapt to regenerative therapies.

Annual Meeting
Read Full Story

Apply Now for 2021 Awards

ASGCT Staff | June 01, 2021

ASGCT is awarding nearly $1 million to our members to support career development, equity, and research on conditions disproportionately affecting minorities.

Read Full Story

COVID-19 Vaccines to the Rescue

Edith Pfister, Ph.D. | May 28, 2021

During this special symposium at the Annual Meeting, panelists Sarah Gilbert, Ph.D., Larry Corey, M.D., Gregory Poland, M.D., Ligia Pinto, Ph.D., Philip Dormitzer, M.D., Ph.D., and Stephen Russell, M.D., Ph.D. talked about lessons learned during the pandemic.

Annual Meeting
Read Full Story

An Interview with University of Oxford Professor Matthew Wood

Eoghan J. Mulholland, Ph.D. | May 27, 2021

Eoghan J. Mulholland, Ph.D., talked to University of Oxford professor Matthew Wood about the UK's new Nucleic Acid Therapy Accelerator (NATA).

Read Full Story

Gene Therapy Progress: Challenges and Opportunities

Emily Walsh Martin, Ph.D. | May 26, 2021

Emily Walsh Martin, Ph.D., recommends two sessions to watch from the 24th Annual Meeting. 

Annual Meeting
Read Full Story

Celebrating Milestones at the Presidential Symposium

Kenji Rowel Lim | May 25, 2021

Robert Martuza, M.D., who is known for his pioneering work on oncolytic viruses, discussed uniting genetic engineering, virology, immunology, and cancer research, during his talk at the 24th Annual Meeting.

Annual Meeting
Read Full Story

Regulatory Lessons Learned From COVID-19: Anomaly to Precedent

Megan Zoschg Canniere, PharmD | May 18, 2021

This summary highlights valuable insights from regulatory leaders at FDA and EMA, among other speakers, from the Annual Meeting session, Regulatory Lessons Learned From COVID-19: Anomaly to Precedent.

Annual Meeting
Read Full Story

There Has Never Been a Better Time to Get into Gene Editing, Doudna Says

Edith Pfister, Ph.D. | May 18, 2021

In a fireside chat on the first day of the 24th Annual Meeting, Jennifer Doudna said the field needs energetic, passionate people to bring ingenuity. 

Annual Meeting
Read Full Story

Watch Annual Meeting Sessions On Demand

ASGCT Staff | May 18, 2021

While we work to build pages on ASGCT.org that will house the meeting content, you can watch it on the meeting platform through August 13.

Annual Meeting
Read Full Story
2021

ASGCT Policy Summit

September 22-24, 2021

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.